You have 9 free searches left this month | for more free features.

amyloidosis

Showing 51 - 75 of 760

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma, AL Amyloidosis Trial in New York (Siltuximab, The M.D. Anderson Symptom Inventory (MDASI))

Active, not recruiting
  • Multiple Myeloma
  • AL Amyloidosis
  • Siltuximab
  • The M.D. Anderson Symptom Inventory (MDASI)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 23, 2023

Light Chain (AL) Amyloidosis Trial in New York (STI-6129)

Recruiting
  • Light Chain (AL) Amyloidosis
  • STI-6129
  • Duarte, California
  • +3 more
Jan 12, 2023

ATTR Amyloidosis Trial in Pavia

Recruiting
  • ATTR Amyloidosis
    • Pavia, Italy
      Fondazione IRCCS Policlinico San Matteo
    Jul 13, 2022

    Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,

    Active, not recruiting
    • Light Chain Deposition Disease
    • Primary Systemic Amyloidosis
    • Denver, Colorado
    • +4 more
    Jan 20, 2023

    Native T1 CMR Imaging for Diagnosis of Cardiac Amyloidosis

    Recruiting
    • Heart Failure NYHA Class II
    • +6 more
    • Native T1 CMR
    • +4 more
    • Leipzig, Saxony, Germany
      University of Leipzig
    Nov 3, 2022

    Transthyretin Amyloidosis, Heart Failure, Heart Failure, Diastolic Trial in Boston (99mTc-pyrophosphate Scintigraphy)

    Recruiting
    • Transthyretin Amyloidosis
    • +3 more
    • 99mTc-pyrophosphate Scintigraphy
    • Boston, Massachusetts
      Massachusetts General Hospital
    Oct 11, 2022

    Hereditary Transthyretin Amyloidosis Patients Included in

    Completed
    • Hereditary Transthyretin Amyloidosis (ATTRv)
    • Polyneuropathy
    • Barcelona, Spain
    • +2 more
    Dec 23, 2022

    Amyloidosis Trial in Detroit (Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app))

    Recruiting
    • Amyloidosis
    • Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app)
    • Detroit, Michigan
      Karmanos Cancer Institute
    Feb 17, 2023

    AL Amyloidosis Trial in Catanzaro, Pavia, Rome (daratumumab and pomalidomide)

    Recruiting
    • AL Amyloidosis
    • daratumumab and pomalidomide
    • Catanzaro, Italy
    • +2 more
    Aug 3, 2022

    Cardiac Amyloidosis Trial in Seoul

    Recruiting
    • Cardiac Amyloidosis
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Sep 6, 2022

      Transthyretin Amyloid Cardiopathy, Mitochondrial Pathology Trial in Aarhus N (Trimetazidine, Placebo)

      Recruiting
      • Transthyretin Amyloid Cardiopathy
      • Mitochondrial Pathology
      • Aarhus N, Danmark, Denmark
        Aarhus University Hospital, Department of Cardiology
      Jan 26, 2023

      Study of Transthyretin-Mediated Amyloidosis

      Recruiting
      • Transthyretin-Mediated Amyloidosis
      • ATTR Amyloidosis
        • La Jolla, California
        • +23 more
        Jan 13, 2023

        Cerebral MRI Anomalies in Mutated Transthyretin Amyloidosis

        Completed
        • Transthyretin Amyloidosis
        • No intervention,
        • Nîmes, France
          CHU de Nîmes
        Sep 1, 2022

        AL Amyloidosis, Light Chain (AL) Amyloidosis, Systemic Light Chain Disease Trial in San Francisco (Venetoclax, Dexamethasone,

        Not yet recruiting
        • AL Amyloidosis
        • +2 more
        • San Francisco, California
          University of California, San Francisco
        Aug 16, 2022

        Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR

        Not yet recruiting
        • Amyloidosis, Hereditary
        • +4 more
          • New York, New York
          • +2 more
          Aug 3, 2022

          Heart Failure, Cardiac Amyloidosis Trial in New Taipei City (Tc-99m PYP Cardiac scan)

          Not yet recruiting
          • Heart Failure
          • Cardiac Amyloidosis
          • Tc-99m PYP Cardiac scan
          • New Taipei City, Taiwan
            Far Eastern Memorial Hospital
          Oct 20, 2022

          Amyloidosis, Primary, Cardiomyopathy Trial in Boston (F-18 florbetapir/C-11 acetate PET, MRI, N-13 ammonia PET)

          Recruiting
          • Amyloidosis, Primary
          • Cardiomyopathy
          • F-18 florbetapir/C-11 acetate PET
          • +2 more
          • Boston, Massachusetts
            Brigham and Womens' Hospital
          Oct 23, 2022

          Transthyroxine Amyloidosis Cardiomyopathy Trial in Hangzhou (ATTR-CM)

          Recruiting
          • Transthyroxine Amyloidosis Cardiomyopathy
          • Hangzhou, Zhejiang, China
            xiaohong University PAN
          Jan 29, 2023

          Amyloid, Amyloidosis, AL Amyloidosis Trial in New York (Selinexor, Dexamethasone)

          Suspended
          • Amyloid
          • +2 more
          • New York, New York
            Weill Cornell Medicine - Multiple Myeloma Center
          May 17, 2022

          Familial Amyloidosis Trial in Nice (Psyllium)

          Recruiting
          • Familial Amyloidosis
          • Psyllium
          • Nice, Provence Alpes Cote d'Azur, France
            University Hospital of Nice
          Jul 1, 2022

          AL Amyloidosis Trial in Worldwide (Belantamab mafodotin)

          Recruiting
          • AL Amyloidosis
          • Belantamab mafodotin
          • Limoges, France
          • +5 more
          Sep 26, 2022

          AL Amyloidosis Trial in Pavia

          Recruiting
          • AL Amyloidosis
            • Pavia, Italy
              Fondazione IRCCS Policlinico San Matteo
            May 4, 2022

            Echocardiographic Parameters Based on Machine Learning Approach

            Not yet recruiting
            • Transthyretin Cardiac Amyloidosis
              • Créteil, France
              • +2 more
              Mar 15, 2023

              Clinical Study for AL-CM

              Recruiting
              • Immunoglobulin Light Amyloidosis Cardiomyopathy
              • current treatment of AL-CM
              • Hangzhou, Zhejiang, China
                2nd Affiliated Hospital, School of Medicine, Zhejiang University
              Jan 29, 2023